NCT00704769View on ClinicalTrials.gov

Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)

CompletedOBSERVATIONAL

Enrollment

591

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Rhinitis

Interventions

DRUG

Desloratadine (assigned by investigator as part of normal practice)

Desloratadine syrup, 2.5 mL (1.25mg) once daily for 2-5 year olds, 5 mL (2.5mg) once daily for 6-11 year olds, minimum 7 days of treatment, minimum of 2 visits

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00704769 - Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299) | Biotech Hunter | Biotech Hunter